The Current Ratio as of December 2024 (TTM) for Mirati Therapeutics, Inc. (MRTX) is 7.54

According to Mirati Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.54. This represents a change of 8.18% compared to the average of 6.97 of the last 4 quarters.

Mirati Therapeutics, Inc. (MRTX) Historical Current Ratio (quarterly & annually)

How has MRTX Current Ratio performed in the past?

The mean historical Current Ratio of Mirati Therapeutics, Inc. over the last ten years is 9.03. The current 7.54 Current Ratio has changed 8.25% with respect to the historical average. Over the past ten years (40 quarters), MRTX's Current Ratio was at its highest in in the December 2020 quarter at 19.64. The Current Ratio was at its lowest in in the June 2014 quarter at 1.10.

Mirati Therapeutics, Inc. (MRTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Mirati Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mirati Therapeutics, Inc. (MRTX) Average Current Ratio

How has MRTX Current Ratio performed in the past?

The current Current Ratio of Mirati Therapeutics, Inc. (MRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mirati Therapeutics, Inc. (MRTX) Current Ratio vs. Peers

How is MRTX’s Current Ratio compared to its peers?

Mirati Therapeutics, Inc.’s Current Ratio is greater than Reata Pharmaceuticals, Inc. (6.75), greater than Sarepta Therapeutics, Inc. (3.84), less than Krystal Biotech, Inc. (7.97), greater than Intercept Pharmaceuticals, Inc. (4.22), less than Day One Biopharmaceuticals, Inc. (14.62), greater than Amylyx Pharmaceuticals, Inc. (4.55), less than Terns Pharmaceuticals, Inc. (32.99), greater than Apellis Pharmaceuticals, Inc. (4.36), less than Madrigal Pharmaceuticals, Inc. (0), greater than Viking Therapeutics, Inc. (5.98), less than Hepion Pharmaceuticals, Inc. (36.47), greater than PTC Therapeutics, Inc. (1.30), greater than Akero Therapeutics, Inc. (2.10), less than null (17.25),

Build a custom stock screener for Mirati Therapeutics, Inc. (MRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mirati Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mirati Therapeutics, Inc. (MRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mirati Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.